The Great Cannabis Debate: Rescheduling, Descheduling, and The Financial Tsunami Ahead!

Cannabis Rescheduling and Financial Impact: What Every Professional Needs to Know

Cannabis rescheduling is making headlines—and for good reason. As the federal government evaluates reclassifying cannabis under the Controlled Substances Act (CSA), professionals across finance, compliance, and cannabis operations are scrambling to understand the financial consequences. In this timely and essential webinar, we break down the Cannabis Rescheduling and Financial Impact from every angle, equipping you with the knowledge to stay ahead in an evolving industry.

This isn’t just about policy. It’s about dollars, decisions, and long-term strategy. Whether you’re a CPA, financial advisor, operator, or policy enthusiast, this session will help you decode the regulatory language and translate it into actionable insights that could make or break your next move.

Why Cannabis Rescheduling Matters

Cannabis is currently classified as a Schedule I substance under the CSA, putting it in the same category as heroin. But that classification is under serious review. A move to Schedule III, or even full descheduling, would drastically alter the financial and compliance landscape. Understanding the Cannabis Rescheduling and Financial Impact now can give you a strategic edge as change approaches.

Key Learning Objectives

In this dynamic session, Naomi Granger, CPA, MBA, will guide participants through critical issues at the intersection of cannabis policy, taxation, and regulation. You’ll walk away with an understanding of:

• The historical context and current classification of cannabis under the Controlled Substances Act.

• The financial and regulatory implications of rescheduling versus descheduling cannabis.

• How cannabis rescheduling may influence banking access, tax treatment (such as 280E), and investor relations.

• The compliance challenges and opportunities emerging from evolving cannabis policy.

• How to anticipate shifts in regulatory oversight and their direct impact on operational practices.

Cannabis Rescheduling and Financial Impact: Implications for Banking and Tax

A key takeaway from our discussion on the Cannabis Rescheduling and Financial Impact is how it affects taxation. Currently, cannabis businesses face extreme tax burdens due to IRS Code 280E, which prohibits deductions and credits for businesses trafficking Schedule I or II substances. Rescheduling cannabis to Schedule III would eliminate this limitation, potentially saving businesses millions.

Similarly, the impact on banking would be profound. Traditional banks remain hesitant to engage with cannabis businesses due to federal prohibition. A rescheduling could ease regulatory fears and open the door to more stable financial services, lending, and investment opportunities.

Compliance and Oversight in a New Era

With Cannabis Rescheduling and Financial Impact comes a new layer of complexity in compliance. Operators must be prepared for changes in state-federal alignment, the introduction of new licensing frameworks, and possibly, FDA oversight if cannabis is moved to Schedule III. The session will cover how these changes could shift recordkeeping requirements, reporting obligations, and audit risk.

Preparing for the Future

While the exact timeline of cannabis rescheduling is uncertain, professionals should begin preparing today. From restructuring entities to revising budgets and forecasts, understanding the Cannabis Rescheduling and Financial Impact allows firms to stay compliant while maximizing profitability.

Who Should Attend?

• Accountants and CPAs working with cannabis clients

• Compliance officers and consultants

• Cannabis operators and license holders

• Legal and financial advisors

• Policy researchers and advocates

This is your opportunity to stay informed, proactive, and profitable in an industry on the verge of historic transformation.

The cannabis industry is evolving faster than ever. With change comes opportunity—but only for those who are prepared. By attending this in-depth session on Cannabis Rescheduling and Financial Impact, you’ll gain the insights needed to navigate the uncertainty with confidence.

Join us for this forward-looking webinar that breaks down complex legislation into clear, actionable steps. Understand the policy. Anticipate the risks. Maximize the rewards.

This Training Qualifies for CPE Credits

LEARNING OBJECTIVES: Cannabis Scheduling

INSTRUCTIONAL DELIVERY METHOD: Group Internet-Based

RECOMMENDED CPE CREDIT: 1 hour

FIELD OF STUDY: Specialized Knowledge

PROGRAM LEVEL: Basic

ADVANCED PREPARATION: None

PREREQUISITES: Accounting professional (CPA not required)

FEE: None*

Green Leaf CFO, LLC is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on accepting individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org

*For more information regarding administrative policies, refund information, or any other feedback, don’t hesitate to get in touch with us at naomi@greenleafcfo.com.

Presented by:

Naomi Granger, CPA, MBA

Meet Naomi Granger, the only CPA to have been featured in The Wall Street Journal for her unique approach to helping accounting professionals expand their practice to support the legal Cannabis industry. She’s provided her support, consulting, and business development skills to over 600 accounting professionals across the United States.

Naomi entered the cannabis industry in 2017 and went from start-up to exceeding $3 million in revenue in just over two years. She’ll guide you to your own solid revenue gains in the highly regulated Cannabis industry with a strong foothold in the market.